Veru Enrolls First Patient in Phase 3 VERACITY Clinical Trial of Sabizabulin…
--Sabizabulin is a novel oral androgen receptor transport disruptor---- In Phase 1b/2 clinical study, sabizabulin was well tolerated with significant antitumor efficacy in metastatic…